Harmonic ACE®+7 Shears in Laparoscopic Hysterectomy
Launched by ETHICON ENDO-SURGERY · Oct 29, 2014
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
Study Population: Subjects enrolled into this study will undergo elective total laparoscopic hysterectomy for benign indications wherein dissection and transection of the uterine vasculature is indicated.
Primary Variables: Percentage of subjects achieving hemostasis at the named vessel/pedicle (UA or UP) on the left side. Percentage of subjects achieving hemostasis at the named vessel/pedicle (UA or UP) on the right side.
Definition: Hemostasis of the named vessel or pedicle is a dichotomous variable (i.e. yes or no). "Yes" is defined as the hemostatic transection of the uterine vasculat...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- Subjects satisfying all of the following criteria will be considered the screening population and will be eligible for participation in this study:
- • 1. Indicated for elective total laparoscopic hysterectomy
- • 2. Age \>=40 years and no future desire for fertility
- Exclusion Criteria:
- Subjects with any of the following criteria will be excluded from the study:
- Preoperative exclusion criteria:
- • 1. Known or suspected uncontrolled bleeding disorders
- • 2. Subjects unlikely to comply with protocol procedures or adhere to the study visit schedule
- • 3. Any condition rendering a subject unable to understand the nature, scope, and possible consequences of the study or study procedures
- • 4. Any Subject unwilling to sign the study informed consent document
- • 5. Any suspected malignancy
- • 6. Any Subject of childbearing potential with a positive or serum pregnancy test within 24 hours prior to surgery
- Intra-operative exclusion criteria:
- • 7. Any intra-operative findings identified by the surgeon that may preclude conduct of the study procedure
About Ethicon Endo Surgery
Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson, is a leading global innovator in surgical devices and technologies, specializing in minimally invasive surgical solutions. With a commitment to advancing patient care, the company focuses on developing cutting-edge products that enhance surgical efficiency and improve patient outcomes. Ethicon Endo-Surgery conducts rigorous clinical trials to evaluate the safety and efficacy of its innovative devices, contributing to the evolution of surgical practices across various specialties. Through collaboration with healthcare professionals and ongoing research, the company aims to set new standards in surgical performance and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Celebration, Florida, United States
Schaumburg, Illinois, United States
Nijmegen, , Netherlands
Surrey, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials